Table: Cosmos Pharmaceutical -2024/25 group results

Cosmos Pharmaceutical

11/07/2025 07:30

Jul 11 (Reuters)- 
          Cosmos Pharmaceutical Corp. 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              May 31, 2025    May 31, 2024   May 31, 2026     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales         1.01 trln        964.99        1.06 trln      525.00   
               (+4.8 pct)      (+16.6 pct)    (+4.5 pct)    (+3.8 pct) 
  Operating       40.40           31.50          40.50         20.42   
               (+28.3 pct)     (+4.6 pct)     (+0.2 pct)    (+0.4 pct) 
  Recurring       43.16           34.30          43.20         21.78   
               (+25.8 pct)     (+3.7 pct)     (+0.1 pct)    (+0.0 pct) 
  Net
  Net             30.98           24.45          31.00         14.65   
               (+26.7 pct)     (+2.8 pct)     (+0.1 pct)    (+1.5 pct) 
  EPS          390.86 yen      308.61 yen     391.13 yen    184.84 yen 
  Ann Div       70.00 yen      120.00 yen      75.00 yen               
  -Q2 Div       32.50 yen       60.00 yen      37.50 yen               
  -Q4 Div       37.50 yen       60.00 yen      37.50 yen               
  
  NOTE - Cosmos Pharmaceutical Corp..
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3349.T